| pubmed-article:9655305 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9655305 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9655305 | lifeskim:mentions | umls-concept:C0241279 | lld:lifeskim |
| pubmed-article:9655305 | lifeskim:mentions | umls-concept:C0221912 | lld:lifeskim |
| pubmed-article:9655305 | lifeskim:mentions | umls-concept:C0005740 | lld:lifeskim |
| pubmed-article:9655305 | lifeskim:mentions | umls-concept:C0678054 | lld:lifeskim |
| pubmed-article:9655305 | lifeskim:mentions | umls-concept:C1512954 | lld:lifeskim |
| pubmed-article:9655305 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:9655305 | pubmed:dateCreated | 1998-7-16 | lld:pubmed |
| pubmed-article:9655305 | pubmed:abstractText | Electrochemotherapy (ECT) is performed by locally administering a chemotherapeutic agent in combination with electric pulses. Previous clinical studies have demonstrated the effectiveness of ECT. In these initial trials, the drug was administered intravenously, followed by administration of electric pulses directly to the tumor. This study was initiated to determine whether an intralesional injection of the drug in combination with electric pulses could provide an improved result. A group of 34 patients was studied. | lld:pubmed |
| pubmed-article:9655305 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9655305 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9655305 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9655305 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9655305 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9655305 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9655305 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:9655305 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:9655305 | pubmed:author | pubmed-author:HellerRR | lld:pubmed |
| pubmed-article:9655305 | pubmed:author | pubmed-author:ReintgenD SDS | lld:pubmed |
| pubmed-article:9655305 | pubmed:author | pubmed-author:DeContiR CRC | lld:pubmed |
| pubmed-article:9655305 | pubmed:author | pubmed-author:GlassL FLF | lld:pubmed |
| pubmed-article:9655305 | pubmed:author | pubmed-author:JaroszeskiM... | lld:pubmed |
| pubmed-article:9655305 | pubmed:author | pubmed-author:PuleoC ACA | lld:pubmed |
| pubmed-article:9655305 | pubmed:author | pubmed-author:GilbertR ARA | lld:pubmed |
| pubmed-article:9655305 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9655305 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:9655305 | pubmed:volume | 83 | lld:pubmed |
| pubmed-article:9655305 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9655305 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9655305 | pubmed:pagination | 148-57 | lld:pubmed |
| pubmed-article:9655305 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9655305 | pubmed:meshHeading | pubmed-meshheading:9655305-... | lld:pubmed |
| pubmed-article:9655305 | pubmed:meshHeading | pubmed-meshheading:9655305-... | lld:pubmed |
| pubmed-article:9655305 | pubmed:meshHeading | pubmed-meshheading:9655305-... | lld:pubmed |
| pubmed-article:9655305 | pubmed:meshHeading | pubmed-meshheading:9655305-... | lld:pubmed |
| pubmed-article:9655305 | pubmed:meshHeading | pubmed-meshheading:9655305-... | lld:pubmed |
| pubmed-article:9655305 | pubmed:meshHeading | pubmed-meshheading:9655305-... | lld:pubmed |
| pubmed-article:9655305 | pubmed:meshHeading | pubmed-meshheading:9655305-... | lld:pubmed |
| pubmed-article:9655305 | pubmed:meshHeading | pubmed-meshheading:9655305-... | lld:pubmed |
| pubmed-article:9655305 | pubmed:meshHeading | pubmed-meshheading:9655305-... | lld:pubmed |
| pubmed-article:9655305 | pubmed:meshHeading | pubmed-meshheading:9655305-... | lld:pubmed |
| pubmed-article:9655305 | pubmed:meshHeading | pubmed-meshheading:9655305-... | lld:pubmed |
| pubmed-article:9655305 | pubmed:meshHeading | pubmed-meshheading:9655305-... | lld:pubmed |
| pubmed-article:9655305 | pubmed:meshHeading | pubmed-meshheading:9655305-... | lld:pubmed |
| pubmed-article:9655305 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9655305 | pubmed:articleTitle | Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. | lld:pubmed |
| pubmed-article:9655305 | pubmed:affiliation | Department of Surgery, University of South Florida, Tampa 33612-4799, USA. | lld:pubmed |
| pubmed-article:9655305 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9655305 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655305 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655305 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655305 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655305 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655305 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655305 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655305 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655305 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655305 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655305 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9655305 | lld:pubmed |
